Thomas Beck
Chairman at Swedish Pharmaceutical Society
Profile
Thomas Beck currently works at Swedish Pharmaceutical Society, as Chairman.
Mr. Beck also formerly worked at AstraZeneca AB, as Associate Director-Quality Assurance from 2006 to 2010, Recipharm Stockholm AB, as Director from 2010 to 2015, Vivendi Universal AB, as Director-Development & Projects from 2000 to 2001, and Recipharm AB, as Vice President-Quality Management from 2015 to 2021.
Mr. Beck received his graduate degree in 1995 from Royal Institute of Technology.
Thomas Beck active positions
| Companies | Position | Start |
|---|---|---|
| Swedish Pharmaceutical Society | Chairman | - |
Former positions of Thomas Beck
| Companies | Position | End |
|---|---|---|
| RECIPHARM AB (PUBL) | Corporate Officer/Principal | 2021-09-30 |
| Recipharm Stockholm AB | Director/Board Member | 2014-12-31 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 2010-10-31 |
Vivendi Universal AB
 Vivendi Universal AB Publishing: Books/MagazinesConsumer Services Vivendi Universal AB publishes music. | Corporate Officer/Principal | 2001-02-28 |
Training of Thomas Beck
| Royal Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
| Swedish Pharmaceutical Society | |
| Recipharm Stockholm AB | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Vivendi Universal AB
Vivendi Universal AB Publishing: Books/MagazinesConsumer Services Vivendi Universal AB publishes music. | Consumer Services |
- Stock Market
- Insiders
- Thomas Beck
